Skip to main content

EDITORIAL article

Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1486819
This article is part of the Research Topic Novel Preclinical Model, Biomarker, Treatment and Drug Delivery to Address Immune Evasion in Cancer View all 12 articles

Editorial: Novel Preclinical Model, Biomarker, Treatment and Drug Delivery to Address Immune Evasion in Cancer

Provisionally accepted
  • 1 Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia
  • 2 Institute for Advanced Biosciences, France, Grenoble, France
  • 3 University Hospital Grenoble, Grenoble, France
  • 4 University of Technology Sydney, Sydney, New South Wales, Australia
  • 5 Sunway University, Bandar Sunway, Selangor Darul Ehsan, Malaysia
  • 6 Monash University Malaysia, Subang Jaya, Selangor, Malaysia

The final, formatted version of the article will be published soon.

    Keywords: cancer immunology, Cancer, modeling, biomarker, Treatment

    Received: 27 Aug 2024; Accepted: 03 Sep 2024.

    Copyright: © 2024 Mai, MACEK JILKOVA, Dua and Goh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Chun Wai Mai, Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.